A comprehensive view of wearable devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AbbVie reports FDA has requested further information on subcutaneous pump used in its ABBV-951 combination therapy to treat Parkinson’s disease; treatment uses foscarbidopa and foslevodopa along with pump device

Stevanato and Thermo Fisher to develop a fully integrated on-body delivery system for subcutaneous drug administration; semi-reusable device to provide micro-precision basal doses and full-content bolus injections for a wide range of therapies

FDA clears Abbott's FreeStyle Libre 2 and FreeStyle Libre 3 sensors for integration with automated insulin delivery systems; sensors also cleared for use by children as young as two years old, pregnant women with diabetes, and for wear time up to 15 days

Medicare to expand continuous glucose monitor coverage to a larger group of patients staring in April, which could double the market for the devices; about 25% of people with Type 2 diabetes currently use a CGM

Apple reportedly working on device to monitor blood glucose without pricking skin; Apple investigating use of silicon photonics chips, optical absorption spectroscopy to determine glucose levels in interstitial fluid below the skin

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count